Variant report
Variant | nsv892253 |
---|---|
Chromosome Location | chr9:9249912-9287321 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144912234 | chr9:9256034-9256035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185158365 | chr9:9256057-9256058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190352358 | chr9:9256069-9256070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543968483 | chr9:9256092-9256093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562365613 | chr9:9256136-9256137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs578134942 | chr9:9256143-9256144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs547990089 | chr9:9256157-9256158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532536764 | chr9:9256180-9256181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149103546 | chr9:9256189-9256190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143197629 | chr9:9256205-9256206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571956916 | chr9:9256210-9256211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs73641278 | chr9:9256264-9256265 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs147812282 | chr9:9256267-9256268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182037943 | chr9:9256272-9256273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536888698 | chr9:9256309-9256310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79849173 | chr9:9256376-9256377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566982569 | chr9:9256387-9256388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533925006 | chr9:9256399-9256400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535599969 | chr9:9256401-9256402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529501463 | chr9:9256408-9256409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558542545 | chr9:9256462-9256463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576697694 | chr9:9256478-9256479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141342022 | chr9:9256490-9256491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75498167 | chr9:9256507-9256508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4628307 | chr9:9256524-9256525 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs569197682 | chr9:9256528-9256529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114815779 | chr9:9256539-9256540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558917987 | chr9:9256544-9256545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536230951 | chr9:9256545-9256546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527418861 | chr9:9256556-9256557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74847042 | chr9:9256562-9256563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564094913 | chr9:9256580-9256581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532812784 | chr9:9256603-9256604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116650538 | chr9:9256608-9256609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569578461 | chr9:9256634-9256635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187470729 | chr9:9256638-9256639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551444028 | chr9:9256653-9256654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189599662 | chr9:9256775-9256776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571222658 | chr9:9256780-9256781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs75042424 | chr9:9256803-9256804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs180848216 | chr9:9256821-9256822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534048517 | chr9:9256851-9256852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs143137073 | chr9:9256905-9256906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs201711114 | chr9:9256932-9256933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570522734 | chr9:9256948-9256949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537889422 | chr9:9256950-9256951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114669237 | chr9:9256958-9256959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs115127644 | chr9:9256974-9256975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs141487698 | chr9:9260251-9260252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572814243 | chr9:9260253-9260254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9256000-9257000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr9:9260200-9260600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr9:9270200-9270600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr9:9283600-9284400 | Enhancers | Fetal Kidney | kidney |